MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Tango Therapeutics, Inc.

TNGX

#1968
Tango Therapeutics, Inc.
11.14
+0.81%
Sector:
Base:
Profit Currency:
Daily Range
11.14
11.14
Year Range
1.03
13.60
Daily Change
+0.81%
Monthly Change
-7.32%
6 month change
+60.75%
Year Change
+413.36%
Previous Close
11.05
Open
11.14
Bid
Ask
Low
11.14
High
11.14
Volume
136
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. TNGX
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

News

Investing Investing
BMY TNGX
2 days ago, 19:14
Stifel reiterates Tango Therapeutics stock rating at Buy
Zacks Zacks
BMY SMMT RVMD TNGX
2 days ago, 14:38
RVMD Reports Wider-Than-Expected Q4 Loss, Issues 2026 Expense View
Investing Investing
TNGX
2026.02.23
Tango Therapeutics stock hits 52-week high at 13.5 USD
Investing Investing
TNGX
2026.02.23
Mizuho initiates Tango Therapeutics stock with outperform rating
Investing Investing
TNGX
2026.02.13
Tango Therapeutics stock hits 52-week high at $13.47
Investing Investing
TNGX
2026.02.05
Tango Therapeutics CFO sells $126,530 in TNGX stock
Investing Investing
TNGX
2026.01.16
Tango Therapeutics stock hits 52-week high at 12.65 USD
Seeking Alpha Seeking Alpha
TNGX
2026.01.14
Tango Therapeutics, Inc. (TNGX) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:TNGX) 2026-01-14
Seeking Alpha Seeking Alpha
TNGX
2026.01.14
Tango Therapeutics, Inc. (TNGX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Investing Investing
TNGX
2026.01.12
Tango Therapeutics stock maintains Buy rating at Stifel on encouraging early data
Investing Investing
TNGX
2026.01.08
Tango Therapeutics appoints Malte Peters as new CEO
Investing Investing
VSTM ABBV RVMD TNGX ERAS
2026.01.07
Revolution Medicines stock surges over 20% on potential AbbVie acquisition

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd